ATE374944T1 - Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung - Google Patents

Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung

Info

Publication number
ATE374944T1
ATE374944T1 AT02792319T AT02792319T ATE374944T1 AT E374944 T1 ATE374944 T1 AT E374944T1 AT 02792319 T AT02792319 T AT 02792319T AT 02792319 T AT02792319 T AT 02792319T AT E374944 T1 ATE374944 T1 AT E374944T1
Authority
AT
Austria
Prior art keywords
antigen
identification
antibodies
limited dilution
molecules
Prior art date
Application number
AT02792319T
Other languages
English (en)
Inventor
John Babcook
Jaspal Kang
Xiao-Chi Jia
Li Zhang
Original Assignee
Abgenix Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23319750&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE374944(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abgenix Inc filed Critical Abgenix Inc
Application granted granted Critical
Publication of ATE374944T1 publication Critical patent/ATE374944T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Carbon And Carbon Compounds (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
AT02792319T 2001-12-03 2002-12-02 Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung ATE374944T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33725001P 2001-12-03 2001-12-03

Publications (1)

Publication Number Publication Date
ATE374944T1 true ATE374944T1 (de) 2007-10-15

Family

ID=23319750

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02792319T ATE374944T1 (de) 2001-12-03 2002-12-02 Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung

Country Status (8)

Country Link
US (1) US7754433B2 (de)
EP (1) EP1554576B9 (de)
AT (1) ATE374944T1 (de)
AU (1) AU2002357779A1 (de)
CA (1) CA2478547C (de)
DE (1) DE60222816T2 (de)
ES (1) ES2294193T3 (de)
WO (1) WO2003048730A2 (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60222816T2 (de) 2001-12-03 2008-07-03 Amgen Fremont Inc. Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung
US7285269B2 (en) 2002-12-02 2007-10-23 Amgen Fremont, Inc. Antibodies directed to tumor necrosis factor
KR20130065723A (ko) 2003-06-27 2013-06-19 암젠 프레몬트 인코포레이티드 상피 성장 인자 수용체의 결실 돌연변이체 지향 항체 및 그 용도
CN101048426A (zh) * 2004-10-22 2007-10-03 金克克国际有限公司 分离人抗体
EP1824886B1 (de) 2004-11-17 2010-12-22 Amgen Inc. Vollständige humane monoklonale antikörper gegen il-13
MX2007013058A (es) 2005-04-20 2008-02-22 Amgen Fremont Inc Anticuerpos monoclonales de alta afinidad completamente humanos para interleucina-8 y epitopes para dichos anticuerpos.
AR056857A1 (es) 2005-12-30 2007-10-24 U3 Pharma Ag Anticuerpos dirigidos hacia her-3 (receptor del factor de crecimiento epidérmico humano-3) y sus usos
US20070207141A1 (en) 2006-02-28 2007-09-06 Ivan Lieberburg Methods of treating inflammatory and autoimmune diseases with natalizumab
MX2008011176A (es) 2006-03-03 2008-09-10 Elan Pharm Inc Metodos para tratar padecimientos inflamatorios y autoinmunes con natalizumab.
KR101790802B1 (ko) 2009-09-03 2017-10-27 머크 샤프 앤드 돔 코포레이션 항-ｇｉｔｒ 항체
EP2896632B1 (de) 2009-11-13 2017-10-25 Daiichi Sankyo Europe GmbH Material und Verfahren zur Behandlung oder Vorbeugung von HER-3-assoziierten Erkrankungen
US11287423B2 (en) 2010-01-11 2022-03-29 Biogen Ma Inc. Assay for JC virus antibodies
DK2715352T3 (da) * 2011-05-31 2019-05-20 Biogen Ma Inc Fremgangsmåde til vurdering af risiko for pml
PE20141937A1 (es) 2011-11-16 2014-12-18 Amgen Inc Metodos para tratar trastornos relacionados con mutante viii de eliminacion de factor de crecimiento epidermico
US9441039B2 (en) 2012-05-07 2016-09-13 Amgen Inc. Anti-erythropoietin antibodies
WO2014193804A1 (en) 2013-05-28 2014-12-04 Biogen Idec Ma Inc. Method of assessing risk of pml
US10422806B1 (en) * 2013-07-25 2019-09-24 Theranos Ip Company, Llc Methods for improving assays of biological samples
EP3112869A1 (de) * 2015-06-30 2017-01-04 IMEC vzw Sensorvorrichtung
CA3042236A1 (en) 2016-10-28 2018-05-03 Washington University Anti-apoe antibodies
AU2020323901A1 (en) 2019-07-26 2022-02-24 Amgen Inc. Anti-IL13 antigen binding proteins
CN114814202A (zh) * 2022-03-25 2022-07-29 浙江工业大学 一种基于96孔板固载分子马达的传感器检测试剂盒、及其用于p24抗原体外检测的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5800815A (en) * 1903-05-05 1998-09-01 Cytel Corporation Antibodies to P-selectin and their uses
US5426029A (en) * 1986-03-31 1995-06-20 T Cell Diagnostics, Inc. Therapeutic and diagnostic methods using leukocyte surface antigens
US5300425A (en) * 1987-10-13 1994-04-05 Terrapin Technologies, Inc. Method to produce immunodiagnostic reagents
US6165469A (en) * 1988-01-13 2000-12-26 University Of Virginia Recombinant Entamoeba histolytica lectin subunit peptides and reagents specific for members of the 170 kD subunit multigene family
NO164622C (no) 1988-05-11 1990-10-24 Tore Lindmo Binaer immunometrisk partikkelbasert metode for maaling av spesifikke serum-antigener ved hjelp av vaeskestroemsmikrofotometri og et ferdigpreparert maaloppsett derav.
US5434076A (en) * 1989-12-18 1995-07-18 Board Of Regents, The University Of Texas System Tumor-specific, cell surface-binding monoclonal antibodies
GB8928874D0 (en) * 1989-12-21 1990-02-28 Celltech Ltd Humanised antibodies
DE69228300T2 (de) * 1991-08-22 1999-09-23 Becton Dickinson And Co., Franklin Lakes Methoden und zusammensetzungen zur krebstherapie und zur vorhersagbarkeit der reaktionen auf diese behandlung
EP2119784A3 (de) 1991-08-23 2010-07-07 Board Of Regents Of The University Of Nebraska Verfahren und Zusammensetzungen zur Zellenumprogrammierung
US5324633A (en) * 1991-11-22 1994-06-28 Affymax Technologies N.V. Method and apparatus for measuring binding affinity
FR2717081B1 (fr) * 1994-03-14 1996-06-21 Centre Nat Rech Scient Rétropeptides, anticorps dirigés contre ces derniers, et leurs utilisations pour la vaccination et le diagnostic in vitro.
US5656499A (en) * 1994-08-01 1997-08-12 Abbott Laboratories Method for performing automated hematology and cytometry analysis
US5874409A (en) * 1995-06-07 1999-02-23 La Jolla Pharmaceutical Company APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
US5834597A (en) * 1996-05-20 1998-11-10 Protein Design Labs, Inc. Mutated nonactivating IgG2 domains and anti CD3 antibodies incorporating the same
US6449562B1 (en) 1996-10-10 2002-09-10 Luminex Corporation Multiplexed analysis of clinical specimens apparatus and method
US20030118985A1 (en) * 1997-05-14 2003-06-26 Hunt Jeffrey C. Mouse monoclonal antibody (5-21-3) to human immunodeficiency virus gp41 protein
US20020155422A1 (en) * 2000-10-20 2002-10-24 Ingber Donald E. Methods for analyzing dynamic changes in cellular informatics and uses therefor
US7135296B2 (en) * 2000-12-28 2006-11-14 Mds Inc. Elemental analysis of tagged biologically active materials
DE60222816T2 (de) 2001-12-03 2008-07-03 Amgen Fremont Inc. Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung
CA2469196A1 (en) * 2001-12-03 2003-06-12 Abgenix, Inc. Discovery of therapeutic products

Also Published As

Publication number Publication date
WO2003048730A3 (en) 2005-05-26
AU2002357779A1 (en) 2003-06-17
CA2478547A1 (en) 2003-06-12
EP1554576B8 (de) 2008-06-11
DE60222816D1 (de) 2007-11-15
EP1554576B1 (de) 2007-10-03
US7754433B2 (en) 2010-07-13
EP1554576B9 (de) 2008-08-20
WO2003048730A2 (en) 2003-06-12
EP1554576A4 (de) 2006-04-05
DE60222816T2 (de) 2008-07-03
EP1554576A2 (de) 2005-07-20
ES2294193T3 (es) 2008-04-01
CA2478547C (en) 2011-09-20
AU2002357779A8 (en) 2003-06-17
US20030186327A1 (en) 2003-10-02

Similar Documents

Publication Publication Date Title
ATE374944T1 (de) Identifizierung hochaffiner moleküle durch screening mit begrenzter verdünnung
EA200500643A1 (ru) Способ неконкурентного иммуноанализа для определения малых аналитов
DE60116172D1 (de) Immunoassay für C-reaktives Protein
AR066204A1 (es) Inmunoglobulina transcitotica
DK1562972T3 (da) Modifikation af FcRn-bindingsaffiniteter eller serumhalveringstider for antistoffer ved mutagenese
ATE449337T1 (de) Assay
ATE410684T1 (de) Molekular-modifikations-assays
WO2002090983A3 (de) Quantitaver einschritt immuntest in lyophilisierter form
EA201100527A1 (ru) Биологические продукты
ATE487946T1 (de) Analytischer sandwichtest zur bestimmung von nt- probnp
DE60330893D1 (de) Intrazelluläre antikörper
EP3300739A3 (de) An 161p2f10b-proteine bindende antikörper und zugehörige moleküle
WO2018232278A3 (en) PHOSPHO-RAB ANTIBODIES, ASSAYS AND METHODS OF USE
Brgles et al. Identification of proteins interacting with ammodytoxins in Vipera ammodytes ammodytes venom by immuno-affinity chromatography
WO2007067983A3 (en) Sulfotyrosine specific antibodies and uses therefor
EP1308730A4 (de) Verfahren zum nachweis oder zum bestimmen von hbv
Spinks et al. Development of an ELISA for paraquat; improvement of antibody characteristics by reversed affinity chromatography
ATE259065T1 (de) Verfahren zum nachweis von helicobacter pylori und heilmanii
NO20052870D0 (no) Immunoanalysemetode og sett for anvendelse derav
EA200100287A1 (ru) Высокоаффинные антитела
DE602007001688D1 (de) Ig-assay
FR2807438B1 (fr) Nouveaux anticorps reconnaissant specifiquement le psa libre inactif, et leurs applications
ATE532074T1 (de) Auf multi-immunoaffinität basierende indentifizierung von antigenen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties